NCT04838184

Short Implants in Edentulous Mandible

Prospective Clinical Study of Straumann Roxolid®/SLactive® Short Implants in Edentulous Mandible

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 20 (actual)
• Sponsor: Universitätsklinikum Hamburg-Eppendorf · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Accepted

Summary

Main aim of this study was to assess survival rates of short implants with a length of 4 mm in the edentulous mandible after 1, 3, and 5 years.

Detailed description

It is hypothesized that survival rates after 1, 3, and 5 years of Straumann Roxolid® / SLActive® 4 mm short implants do not differ from values of Straumann SLActive implants with more than 4 mm length in the same clinical situation.

Conditions

• Tooth Loss
• Edentulous Jaw

Interventions

Type	Name	Description
DEVICE	Dental Implants (Straumann Roxolid® / SLActive®)	In this study the 4 mm implants will be inserted in the area surrounding 36/46. The implant diameters will be defined based on the patient's situation. In the interforaminal region, two implants of conventional length with a minimum of 10 mm will be inserted. The implant diameter and the length will be defined based on the patient's situation.

Timeline

• Start date: 2015-04-19
• Primary completion: 2024-03-31
• Completion: 2024-03-31
• First posted: 2021-04-09
• Last updated: 2021-04-09